192 related articles for article (PubMed ID: 26014517)
1. SEMA6A is a prognostic biomarker in glioblastoma.
Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P
Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517
[TBL] [Abstract][Full Text] [Related]
2. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
3. Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells.
Kwon RJ; Han ME; Kim YJ; Kim YH; Kim JY; Liu L; Heo W; Oh SO
Tumour Biol; 2017 Mar; 39(3):1010428317694575. PubMed ID: 28351300
[TBL] [Abstract][Full Text] [Related]
4. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.
Quan J; Li Y; Jin M; Chen D; Yin X; Jin M
Tumour Biol; 2017 Mar; 39(3):1010428317694572. PubMed ID: 28351326
[TBL] [Abstract][Full Text] [Related]
5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
8. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
[TBL] [Abstract][Full Text] [Related]
10. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
11. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
12. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
13. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
Sharma I; Singh A; Siraj F; Saxena S
J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
[TBL] [Abstract][Full Text] [Related]
15. High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
Kamil M; Shinsato Y; Higa N; Hirano T; Idogawa M; Takajo T; Minami K; Shimokawa M; Yamamoto M; Kawahara K; Yonezawa H; Hirano H; Furukawa T; Yoshimoto K; Arita K
Br J Cancer; 2019 Apr; 120(8):819-826. PubMed ID: 30867563
[TBL] [Abstract][Full Text] [Related]
16. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
[TBL] [Abstract][Full Text] [Related]
17. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
Ji X; Zhu H; Dai X; Xi Y; Sheng Y; Gao C; Liu H; Xue Y; Liu J; Shi J; Zhang Y; Chen Y; Dai X; Li M; Wang A; Dong J
Cancer Biomark; 2019; 25(3):275-290. PubMed ID: 29991124
[TBL] [Abstract][Full Text] [Related]
19. Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1.
DU K; Wu X; Ji X; Liang N; Li Z
J Neurosurg Sci; 2023 Aug; 67(4):422-430. PubMed ID: 33297605
[TBL] [Abstract][Full Text] [Related]
20. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
